News Breaks |
|
|
| October 15, 2012 |
| 04:55 EDT |  | EW, EW, EW, HOLX, HOLX, HOLX, SYK, SYK, SYK, MDT, MDT, MDT, ONCS, ONCS, ONCS, AEMD, AEMD, AEMD | Elsevier Business Intelligence to host a summit IN3 Medical Device 360 Summit is being held in San Francisco on October 15-17. |
|
|
News For EW;HOLX;SYK;MDT;ONCS;AEMD From The Last 14 Days Check below for free stories on EW;HOLX;SYK;MDT;ONCS;AEMD the last two weeks. |
|
|
| May 17, 2013 |
| 10:07 EDT |  | SYK | On The Fly: Analyst Downgrade Summary Today's noteworthy downgrades include: Actuant (ATU) downgraded to Neutral from Buy at SunTrust... Aruba Networks (ARUN) downgraded to Perform from Outperform at Oppenheimer... CAE (CAE) downgraded to Sector Perform from Outperform at RBC Capital... City Holding (CHCO) downgraded to Market Perform from Outperform at Keefe Bruyette... Deere (DE) downgraded to Sell from Neutral at Goldman... Disney (DIS) downgraded to Neutral from Overweight at Atlantic Equities... HSBC (HBC) downgraded to Neutral from Outperform at Exane BNP Paribas... L Brands (LTD) downgraded to Underperform from Hold at Jefferies... Manning & Napier (MN) downgraded to Underperform from Neutral at BofA/Merrill... MeadWestvaco (MWV) downgraded to Underperform from Sector Perform at RBC Capital... National Grid (NGG) downgraded to Neutral from Outperform at Exane BNP Paribas... Savient (SVNT) downgraded to Market Perform from Outperform at William Blair... Stryker (SYK) downgraded to Reduce from Neutral at SunTrust... TRW Automotive (TRW) downgraded to Hold from Buy at Deutsche Bank... Universal Health (UHS) downgraded to Neutral from Positive at Susquehanna... Williams-Sonoma (WSM) downgraded to Neutral from Buy at BofA/Merrill... Zimmer (ZMH) downgraded to Reduce from Neutral at SunTrust... Aviva (AV) downgraded to Underperform from Sector Perform at RBC Capital... Pandora (P) downgraded to Hold from Buy at Maxim... Lumos Networks (LMOS) downgraded to Neutral from Buy at DA Davidson... Brocade (BRCD) downgraded to Underperform from Market Perform at William Blair... Applied Materials (AMAT) downgraded to Neutral from Buy at DA Davidson... Cosi (COSI) downgraded to Market Perform from Outperform at Northland Securities. |
|
| 06:22 EDT |  | SYK | Stryker downgraded to Reduce from Neutral at SunTrust
Subscribe for More Information |
|
| May 16, 2013 |
| 13:32 EDT |  | MDT | Medtronic volatility flat into Q4 and outlook
Subscribe for More Information |
|
| 10:03 EDT |  | MDT | On The Fly: Analyst Downgrade Summary
Subscribe for More Information |
|
| 06:32 EDT |  | MDT | Medtronic downgraded to Neutral from Outperform at Credit Suisse
Subscribe for More Information |
|
| May 15, 2013 |
| 14:02 EDT |  | HOLX | Leerink's medical devices analyst holds a conference call Medical Devices Analyst Newitter discusses Hologic's tomosynthesis (3D) technology on an Analyst/Industry conference call to be held on May 16 at 2:30 pm. |
|
| 07:17 EDT |  | EW | Edwards Lifesciences share repurchases positive, says Wells Fargo
Subscribe for More Information |
|
| May 14, 2013 |
| 09:27 EDT |  | EW | Edwards Lifesciences CEO to purchase $5M of company stock The company announced that Michael A. Mussallem, Edwards' chairman and CEO, will make a $5M cash purchase of newly issued shares of Edwards common stock. |
|
| 09:26 EDT |  | EW | Edwards Lifesciences announces new $750M share repurchase program Edwards Lifesciences announced that its board has authorized a new share repurchase program to acquire up to an additional $750M of the company's outstanding common shares. As of March 31, Edwards had approximately $140M remaining of its current $500M share repurchase program, which was authorized in September 2011. Edwards expects to utilize the remainder of the $500M repurchase authorization during Q2. |
|
| 09:22 EDT |  | EW | Edwards Lifesciences CFO announces retirement Edwards Lifesciences announced that Thomas M. Abate, the company's CFO, plans to retire later this year. Abate plans to remain CFO until his successor is in place. The company has retained Peter Crist of Crist/Kolder Associates to assist in the CFO search. |
| |
| May 10, 2013 |
| 15:49 EDT |  | MDT | Medtronic defibrillators demonstrate success of shock avoidance
Subscribe for More Information |
|
| May 8, 2013 |
| 07:38 EDT |  | SYK, MDT | BofA/Merrill's medical tech analyst hold an analyst/industry conference call
Subscribe for More Information |
|
| May 7, 2013 |
| 12:29 EDT |  | HOLX | High option volume stocks: GNK CVR ACM BA HOLX
Subscribe for More Information |
|
| 10:00 EDT |  | HOLX | On The Fly: Analyst Downgrade Summary Today's noteworthy downgrades include: Aeropostale (ARO) downgraded to Sell from Hold at Brean Capital... AIG (AIG) downgraded to Neutral from Buy at Goldman... Alpha Natural (ANR) downgraded to Sell from Neutral at Goldman... American Eagle (AEO) downgraded to Market Perform from Outperform at Wells Fargo... Coach (COH) downgraded to Market Perform from Outperform at Wells Fargo... Iconix Brand (ICON) downgraded to Hold from Buy at Brean Capital... International Rectifier (IRF) downgraded to Market Perform at JMP Securities... Mettler-Toledo (MTD) downgraded to Hold from Buy at Jefferies... TJX (TJX) downgraded to Market Perform from Outperform at Wells Fargo... Tiffany (TIF) downgraded to Market Perform from Outperform at Wells Fargo... North American Palladium (PAL) downgraded to Market Perform at Raymond James... Ducommun (DCO) downgraded to Neutral from Buy at B. Riley... International Rectifier (IRF) downgraded at JMP Securities... Hologic (HOLX) downgraded to Buy from Strong Buy at ISI Group... Ruckus Wireless (RKUS) downgraded to Neutral from Buy at Lazard Capital. |
|
| 09:00 EDT |  | HOLX | Hologic falls 4.2% Hologic is down 4.2%, or 86c, to $19.80 |
|
| 07:24 EDT |  | HOLX | Hologic downgraded to Buy from Strong Buy at ISI Group ISI Group downgraded Hologic following the Q2 report and lowered guidance. |
|
| 06:57 EDT |  | HOLX | Hologic downgraded to Outperform from Strong Buy at Raymond James
|
|
| May 6, 2013 |
| 16:11 EDT |  | HOLX | Hologic sees FY13 adjusted EPS $1.54-$1.56, consensus $1.58
Subscribe for More Information |
|
| 16:10 EDT |  | HOLX | Hologic sees Q3 adjusted EPS 36c-37c, consensus 41c Sees Q3 revenue $625M-$630M, consensus $655.24M. |
|
| 16:09 EDT |  | HOLX | Hologic reports Q2 EPS adjusted EPS 35c, consensus 34c
Subscribe for More Information |
| |
|
|
|
|